Summit Street Capital Management LLC Acquires Shares of 91,449 Humana Inc. $HUM

Summit Street Capital Management LLC purchased a new position in Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 91,449 shares of the insurance provider’s stock, valued at approximately $36,325,000. Humana makes up about 5.1% of Summit Street Capital Management LLC’s holdings, making the stock its 3rd largest position.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Johnson Financial Group Inc. acquired a new position in shares of Humana during the 2nd quarter valued at about $26,000. Trust Co. of Vermont acquired a new stake in Humana during the second quarter worth about $28,000. Bogart Wealth LLC increased its position in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 48 shares during the last quarter. MidFirst Bank purchased a new position in Humana during the second quarter worth about $35,000. Finally, Montag A & Associates Inc. raised its stake in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HUM. Royal Bank Of Canada increased their price target on shares of Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $249.00 to $370.00 in a research report on Tuesday, August 4th. JPMorgan Chase & Co. raised their target price on Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Needham & Company LLC assumed coverage on Humana in a research report on Wednesday, May 20th. They issued a “buy” rating on the stock. Finally, Wolfe Research reaffirmed an “outperform” rating and issued a $450.00 price target on shares of Humana in a research note on Monday. Fourteen research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus price target of $403.91.

Humana Stock Performance

NYSE HUM opened at $390.06 on Thursday. The company has a market cap of $46.84 billion, a P/E ratio of 36.90, a P/E/G ratio of 2.22 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a 50-day moving average of $384.44 and a two-hundred day moving average of $286.38. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter in the prior year, the company earned $6.27 earnings per share. The business’s quarterly revenue was up 26.2% on a year-over-year basis. As a group, analysts anticipate that Humana Inc. will post 9.12 EPS for the current year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.